Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
5. Netzwerktreffen der zertifizierten Hautkrebszentren.
Utikal J, Eigentler T, Huber MA, Meiß F, Schneider LA, Weichenthal M. Utikal J, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2019 Jul;17(7):763-764. doi: 10.1111/ddg.13873. J Dtsch Dermatol Ges. 2019. PMID: 31364288 No abstract available.
6. Netzwerktreffen der zertifizierten Hautkrebszentren.
Utikal J, Huber M, Meier F, Meiß F, Weichenthal M, Schneider LA. Utikal J, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2020 Jul;18(7):783-784. doi: 10.1111/ddg.14129_g. J Dtsch Dermatol Ges. 2020. PMID: 32713139 German. No abstract available.
[First network meeting of the certified skin tumor centers].
Eigentler TK, Utikal J, Huber MA, Meiss F, Schneider LA. Eigentler TK, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2015 Aug;13(8):847-8. doi: 10.1111/ddg.12762. J Dtsch Dermatol Ges. 2015. PMID: 26213830 German. No abstract available.
Zweites Netzwerktreffen der zertifizierten Hauttumorzentren.
Utikal J, Eigentler TK, Huber MA, Meiss F, Weichenthal M, Schneider LA. Utikal J, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2016 Oct;14(10):1051-1052. doi: 10.1111/ddg.13149. J Dtsch Dermatol Ges. 2016. PMID: 27767267 No abstract available.
Intermittent vemurafenib therapy in malignant melanoma.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2017 Apr;15(4):451-454. doi: 10.1111/ddg.13034. Epub 2017 Mar 15. J Dtsch Dermatol Ges. 2017. PMID: 28294514 No abstract available.
Intervalltherapie mit Vemurafenib beim malignen Melanom.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: schneider la. J Dtsch Dermatol Ges. 2017 Apr;15(4):450-453. doi: 10.1111/ddg.13034_g. J Dtsch Dermatol Ges. 2017. PMID: 28378474 No abstract available.
118 results